Skip to main content
. Author manuscript; available in PMC: 2016 Jun 5.
Published in final edited form as: Chem Biol Interact. 2014 Nov 21;234:154–161. doi: 10.1016/j.cbi.2014.11.010

Figure 3.

Figure 3

HPLC chromatograms showing doxorubicinol formation with (A) catalytically inactive and (B) catalytically active purified mCBR3. Doxorubicinol eluted at ~10 minutes, while doxorubicin eluted at ~15 minutes.